Emails reveal how a controversial hepatitis B trial won a $1.6M no‑bid grant
TL;DR Summary
Rolling Stone reports that emails show Health and Human Services officials fast-tracked a $1.6 million, no-bid grant to Danish researchers for a birth-dose hepatitis B trial in Guinea‑Bissau, timed with RFK Jr.’s policy shifts. The funding was pushed as a “funding priority” by Kennedy appointees, drawing ethical concerns over withholding a lifesaving vaccine and raising questions about political influence on research funding.
- HHS Gave a $1.6 Million Grant to a Controversial Vaccine Study. These Emails Show How That Happened Rolling Stone
- Controversial US study on hepatitis B vaccines in Africa is cancelled The Guardian
- CDC funding hepatitis vaccine study in African nation evokes Tuskegee study AJC.com
- Confusion Over 'Cancellation' Of Controversial Hepatitis B Trial In Guinea-Bissau Health Policy Watch
- A Controversial U.S. Study of Hepatitis B Vaccines Will Continue in Africa, HHS says Scientific American
Reading Insights
Total Reads
0
Unique Readers
7
Time Saved
25 min
vs 26 min read
Condensed
99%
5,103 → 62 words
Want the full story? Read the original article
Read on Rolling Stone